MLYS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -1.645, suggesting MLYS is Neutral.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 30.564, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 34.694, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it Sell.

Technical Analysis for MLYS

Technical Sentiment Analysis for Mineralys Therapeutics Inc (MLYS) As of 2026-02-19, Mineralys Therapeutics Inc (MLYS) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 6 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for MLYS stands at 36.539, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -1.645, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 15.263 and the Commodity Channel Index (CCI) at -118.563 further confirm a -2.56 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, MLYS is trading above its 60-day moving average of $34.694 and above its 200-day long-term moving average of $27.93. Key price levels to watch include the immediate resistance at $31.855 and strong support at $26.495. A break above $31.855 could signal a bull continuation, while falling below $26.495 may test the next Fibonacci floor at $23.992.

Mineralys Therapeutics Inc (MLYS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	21.135	23.992	26.495	29.352	31.855	34.712	37.215
Fibonacci	23.992	26.04	27.305	29.352	31.4	32.665	34.712

Mineralys Therapeutics Inc (MLYS) Technical Indicators

2026-02-19

Name	Value
RSI_14	36.539
STOCHk_14_3_3	15.263
STOCHd_14_3_3	10.06
CCI_20	-118.563
AO_5_34	-3.859
MOM_10	-2.56
MACD_12_26_9	-1.645

Mineralys Therapeutics Inc (MLYS) Relative Strength Index (RSI) is 36.539, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic Oscillator is 15.263, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Stochastic RSI is 10.06, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Commodity Channel Index (CCI) is -118.563, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Awesome Oscillator is -3.859, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Momentum is -2.56, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) MACD is -1.645, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Moving Average

2026-02-19

Period	Simple	Signal
MA_5	27.88	Buy
MA_10	28.997	Sell
MA_20	30.564	Sell
MA_60	34.694	Sell
MA_200	27.93	Buy
MA_250	24.989	Buy

Mineralys Therapeutics Inc (MLYS) 5-Day simple moving average is 27.88, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 10-Day simple moving average is 28.997, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 30.564, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 34.694, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 200-Day simple moving average is 27.93, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 250-Day simple moving average is 24.989, while Mineralys Therapeutics Inc (MLYS) share price is $28.06, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for MLYS?

The overall technical consensus for Mineralys Therapeutics Inc (MLYS) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 4 sell signals.

What are the key support and resistance levels for Mineralys Therapeutics Inc (MLYS) today?

Based on pivot point calculations, Mineralys Therapeutics Inc (MLYS) has an immediate support level at 26.495 and a major resistance level at 31.855. Traders also monitor the pivot point at 29.352 to determine the intraday trend direction.

Is Mineralys Therapeutics Inc (MLYS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Mineralys Therapeutics Inc (MLYS) is currently 36.539. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Mineralys Therapeutics Inc (MLYS)?

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -1.645, suggesting MLYS is Neutral. This indicator helps identify potential trend reversals or momentum shifts for Mineralys Therapeutics Inc.

How is Mineralys Therapeutics Inc (MLYS) performing relative to its 200-day moving average?

Mineralys Therapeutics Inc (MLYS) is currently trading at $28.06, which is above its 200-day simple moving average of 27.93. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.